Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2026)
Rezolute's (RZLT) quarterly Other Non-Current Liabilities came in at $483000.0 in Q1 2026, little changed year-on-year from $483000.0 in Q1 2025, and little changed quarter-over-quarter from $483000.0 in Q4 2025.
Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Rezolute has disclosed Other Non-Current Liabilities across 13 years of filings, most recently posting $483000.0 for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $483000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $483000.0 (changed 0.0% YoY), and the FY2025 annual result was $468000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities came in at $483000.0 for Q1 2026 at Rezolute, roughly flat from $483000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $483000.0 in Q3 2024 to a low of $395000.0 in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $453000.0 (2024), against an average of $450647.1.
- Across the five-year window, Other Non-Current Liabilities increased 13.59% in 2024 and changed 0.0% in 2025, its largest moves.
- Rezolute's Other Non-Current Liabilities stood at $434000.0 in 2022, then rose by 1.15% to $439000.0 in 2023, then climbed by 8.66% to $477000.0 in 2024, then climbed by 1.26% to $483000.0 in 2025, then changed by 0.0% to $483000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $483000.0 (Q1 2026), $483000.0 (Q4 2025), and $483000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 483,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 483,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 483,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | 453,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Sep 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 412,000.00 |
| Mar 31, 2023 | 447,000.00 |
| Dec 31, 2022 | 434,000.00 |
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 407,000.00 |
| Mar 31, 2022 | 395,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 387,000.00 |